Patient Navigation Program for Cancer

Not yet recruiting at 1 trial location
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: University of Southern California
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a special program designed to help American Indian and Alaska Native cancer patients in rural California access treatment more quickly after diagnosis. The program, Community-Focused Patient Navigation (CFPN), addresses the cultural needs of these communities and aims to overcome barriers like rural isolation and distrust in healthcare. By guiding patients through the healthcare system, the trial seeks to reduce delays in receiving appropriate care. This trial may suit those with any type of cancer who live in the Toiyabe Indian Health Program area and identify as American Indian, Alaska Native, or are patients of the Toiyabe Indian Health Program. As an unphased trial, it focuses on improving patient access and support, offering a unique opportunity to contribute to community health advancements.

What prior data suggests that the Community-Focused Patient Navigation program is safe for cancer patients?

Research has shown that programs like the Community-Focused Patient Navigation (CFPN) are generally safe. These programs assist cancer patients by guiding them through the healthcare system and reducing treatment delays. Without direct medical treatment involved, participants need not worry about side effects like those from a new drug.

Studies have found that patient navigation improves cancer care and reduces disparities in care quality and access without causing harm. The CFPN program specifically supports American Indian and Alaska Native communities, offering a culturally sensitive approach.

Overall, the CFPN program provides help and support, not medical treatment or medication, making it safe and well-tolerated for participants.12345

Why are researchers excited about this trial?

Researchers are excited about the Community-Focused Patient Navigation (CFPN) program because it offers a personalized approach to cancer care, tailored to each patient's unique needs, goals, and barriers. Unlike standard treatments that may not address individualized obstacles, the CFPN program provides education on opioid misuse and coordinates care to ensure comprehensive support. This program aims to empower patients by involving them in designing the navigation process, which could lead to more effective and patient-centered cancer care solutions.

What evidence suggests that the Community-Focused Patient Navigation program is effective for reducing delays in cancer treatment for American Indian and Alaska Native patients?

Research has shown that patient navigation programs can help reduce delays in cancer treatment. These programs guide patients through the healthcare system and address challenges such as living in remote areas and mistrust of healthcare providers. Studies have found that patient navigation increases cancer screening rates and improves access to treatment, especially when navigators share cultural backgrounds with the patients. For American Indian and Alaska Native communities, culturally informed navigation is essential. It can lead to better outcomes by providing support tailored to their specific needs and challenges. This trial evaluates the Community-Focused Patient Navigation (CFPN) program for its effectiveness in reducing treatment delays for cancer patients.12678

Who Is on the Research Team?

CS

Claradina Soto

Principal Investigator

University of Southern California

Are You a Good Fit for This Trial?

This trial is for American Indian and Alaska Native cancer patients living in rural California who experience delays between diagnosis and treatment. It aims to help those facing barriers like rural isolation, complex referral systems, or distrust in healthcare.

Inclusion Criteria

KII: Work with AIAN cancer patients in TIHP catchment area
CFPN PROGRAM IMPLEMENTATION: Self-identify as AIAN or be a TIHP patient
CFPN PROGRAM IMPLEMENTATION: Live in the TIHP service area
See 12 more

Exclusion Criteria

FOCUS GROUP: Individual with no experience with cancer either as a patient or know someone who is/was a cancer patient at TIHP
CFPN PROGRAM IMPLEMENTATION: Not a TIHP patient
I currently do not have cancer and have never had cancer.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Co-design Process

Participants engage in the co-design process of the CFPN program through Community Advisory Board, focus groups, or key informant interviews

1-2 months
Multiple sessions (in-person or virtual)

CFPN Program Implementation

Patients engage with the CFPN program navigator and receive a treatment plan based on their needs, goals, and barriers

Up to 2 years

Follow-up

Participants are monitored for the effectiveness and implementation of the CFPN program

Up to 2 years

What Are the Treatments Tested in This Trial?

Interventions

  • Community-Focused Patient Navigation (CFPN)

Trial Overview

The trial tests a culturally informed patient navigation program called Community-Focused Patient Navigation (CFPN). It guides patients through the healthcare system with personalized support to overcome barriers and access timely care.

How Is the Trial Designed?

4

Treatment groups

Experimental Treatment

Group I: Objective 2 (CFPN program)Experimental Treatment6 Interventions
Group II: Objective 1 group III (KII)Experimental Treatment1 Intervention
Group III: Objective 1 group II (focus group)Experimental Treatment1 Intervention
Group IV: Objective 1 group I (CAB)Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Southern California

Lead Sponsor

Trials
956
Recruited
1,609,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Pfizer

Industry Sponsor

Trials
4,712
Recruited
50,980,000+
Known For
Vaccine Innovations
Top Products
Viagra, Zoloft, Lipitor, Prevnar 13

Albert Bourla

Pfizer

Chief Executive Officer since 2019

PhD in Biotechnology of Reproduction, Aristotle University of Thessaloniki

Patrizia Cavazzoni profile image

Patrizia Cavazzoni

Pfizer

Chief Medical Officer

MD from McGill University

American Cancer Society, Inc.

Collaborator

Trials
237
Recruited
110,000+

Citations

A Culturally Informed Patient Navigation Program (CFPN) ...

Qualitative Effectiveness of Community-Focused Patient Navigation (CFPN) program, Data collected in interviews focusing on patient's cancer ...

Evaluating implementation of a community-focused patient ...

This study utilized the implementation science evaluation framework, RE-AIM, to evaluate implementation of a community-focused patient navigation program.

A Culturally Informed Patient Navigation Program (CFPN) ...

Using Patient Satisfaction With Cancer Care Scale (Jean-Pierre, 2010) to collect data regarding the effectiveness of the CFPN program. Data will be analyzed ...

4.

pubmed.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov/38685006/

Evaluating implementation of a community-focused patient ...

This study utilized the implementation science evaluation framework, RE-AIM, to evaluate implementation of a community-focused patient navigation program.

Patient Navigation Effectiveness on Improving Cancer ...

Discussion: The results suggest that PN is an effective intervention for increasing cancer screening, with greater effects achieved by professional navigators.

Part I. Achieving Equity in Cancer Care: The Need for ...

In the intervening decades, cancer patient navigation has consistently been demonstrated to improve outcomes; reduce disparities in cancer care; ...

Enabling Personalized Needs-Based Cancer Patient ...

Evidence suggests that patient navigation can help address ongoing barriers to accessing timely, appropriate, and quality cancer care.

Navigating a Path to Equity in Cancer Care: The Role of ...

Subsequently, several studies have reported that patient navigation increases screening for breast cancer and gynecologic cancers. Based on this ...